These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
638 related articles for article (PubMed ID: 15822108)
1. Pathophysiology of motor fluctuations in Parkinson's disease. Widnell K Mov Disord; 2005; 20 Suppl 11():S17-22. PubMed ID: 15822108 [TBL] [Abstract][Full Text] [Related]
2. Levodopa-induced dyskinesias in Parkinson's disease: etiology, impact on quality of life, and treatments. Encarnacion EV; Hauser RA Eur Neurol; 2008; 60(2):57-66. PubMed ID: 18480609 [TBL] [Abstract][Full Text] [Related]
3. Levodopa in the treatment of Parkinson's disease: current controversies. Olanow CW; Agid Y; Mizuno Y; Albanese A; Bonuccelli U; Damier P; De Yebenes J; Gershanik O; Guttman M; Grandas F; Hallett M; Hornykiewicz O; Jenner P; Katzenschlager R; Langston WJ; LeWitt P; Melamed E; Mena MA; Michel PP; Mytilineou C; Obeso JA; Poewe W; Quinn N; Raisman-Vozari R; Rajput AH; Rascol O; Sampaio C; Stocchi F Mov Disord; 2004 Sep; 19(9):997-1005. PubMed ID: 15372588 [TBL] [Abstract][Full Text] [Related]
4. [Pharmacological mechanisms of the treatment of dyskinesias in Parkinson disease]. Jiménez-Jiménez FJ; Molina JA; Ortí-Pareja M Rev Neurol; 1999 May 1-15; 28(9):889-98. PubMed ID: 10390756 [TBL] [Abstract][Full Text] [Related]
5. Recognition and treatment of response fluctuations in Parkinson's disease: review article. Verhagen Metman L Amino Acids; 2002; 23(1-3):141-5. PubMed ID: 12373528 [TBL] [Abstract][Full Text] [Related]
6. Effect of bilateral subthalamic nucleus stimulation on levodopa-unresponsive axial symptoms in Parkinson's disease. Yamada K; Goto S; Hamasaki T; Kuratsu JI Acta Neurochir (Wien); 2008 Jan; 150(1):15-22; discussion 22. PubMed ID: 18180867 [TBL] [Abstract][Full Text] [Related]
7. Pathophysiology of levodopa-induced dyskinesias in Parkinson's disease: problems with the current model. Obeso JA; Rodriguez-Oroz MC; Rodriguez M; DeLong MR; Olanow CW Ann Neurol; 2000 Apr; 47(4 Suppl 1):S22-32; discussion S32-4. PubMed ID: 10762129 [TBL] [Abstract][Full Text] [Related]
8. Parkinson's disease: the syndrome, the pathogenesis and pathophysiology. Bartels AL; Leenders KL Cortex; 2009 Sep; 45(8):915-21. PubMed ID: 19095226 [TBL] [Abstract][Full Text] [Related]
9. Drug insight: Continuous dopaminergic stimulation in the treatment of Parkinson's disease. Olanow CW; Obeso JA; Stocchi F Nat Clin Pract Neurol; 2006 Jul; 2(7):382-92. PubMed ID: 16932589 [TBL] [Abstract][Full Text] [Related]
10. Subthalamic nucleus stimulation for Parkinson disease: benefits observed in levodopa-intolerant patients. Katayama Y; Kasai M; Oshima H; Fukaya C; Yamamoto T; Ogawa K; Mizutani T J Neurosurg; 2001 Aug; 95(2):213-21. PubMed ID: 11780890 [TBL] [Abstract][Full Text] [Related]
11. Randomized trial of pallidotomy versus medical therapy for Parkinson's disease. Vitek JL; Bakay RA; Freeman A; Evatt M; Green J; McDonald W; Haber M; Barnhart H; Wahlay N; Triche S; Mewes K; Chockkan V; Zhang JY; DeLong MR Ann Neurol; 2003 May; 53(5):558-69. PubMed ID: 12730989 [TBL] [Abstract][Full Text] [Related]
12. Risk factors in development of motor complications in Chinese patients with idiopathic Parkinson's disease. Kum WF; Gao J; Durairajan SS; Man SC; Xie LX; Lu JH; Fong WL; Li M J Clin Neurosci; 2009 Aug; 16(8):1034-7. PubMed ID: 19428256 [TBL] [Abstract][Full Text] [Related]
13. Glutamate-mediated striatal dysregulation and the pathogenesis of motor response complications in Parkinson's disease. Oh JD; Chase TN Amino Acids; 2002; 23(1-3):133-9. PubMed ID: 12373527 [TBL] [Abstract][Full Text] [Related]
14. Levodopa enhances synaptic plasticity in the substantia nigra pars reticulata of Parkinson's disease patients. Prescott IA; Dostrovsky JO; Moro E; Hodaie M; Lozano AM; Hutchison WD Brain; 2009 Feb; 132(Pt 2):309-18. PubMed ID: 19050033 [TBL] [Abstract][Full Text] [Related]
15. Parkinson's disease--opportunities for novel therapeutics to reduce the problems of levodopa therapy. Fox SH; Chuang R; Brotchie JM Prog Brain Res; 2008; 172():479-94. PubMed ID: 18772047 [TBL] [Abstract][Full Text] [Related]
16. Role of surgery in the treatment of motor complications. Metman LV; O'Leary ST Mov Disord; 2005; 20 Suppl 11():S45-56. PubMed ID: 15822076 [TBL] [Abstract][Full Text] [Related]
18. [Early treatment of Parkinson's disease with levodopa]. Odekerken VJ; Post B; Verschuur CV; de Bie RM Ned Tijdschr Geneeskd; 2009; 153():A286. PubMed ID: 19785822 [TBL] [Abstract][Full Text] [Related]
19. [Fluctuations and dyskinesias as early L-dopa-induced motor complications in severe Parkinsonian's patients]. Vaamonde J; Ibáñez R; Gudín M; Hernández A Neurologia; 2003 Apr; 18(3):162-5. PubMed ID: 12677484 [TBL] [Abstract][Full Text] [Related]